{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-025378","form_type":"8-K","ticker":"DTSQ","cik":"0002017950","company_name":"DT Cloud Star Acquisition Corp","filed_at":"2025-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.325454+00:00","generated_at":"2026-05-16T16:17:36.233745+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"DT Cloud Star Acquisition appoints Dr. Xunyong Zhou as director","bullets":["Dr. Xunyong Zhou appointed as director effective November 26, 2025.","Zhou, 50, has over 6 years of experience in biotechnology and health innovation, holds over 20 patents.","He serves as director of Huakang Biomedical Holdings (HK: 08622) and chairman of Nanjing Hezhen Holding Group.","Zhou holds a doctorate from Université Nice Sophia Antipolis and bachelor's from Tianjin University."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-025378","json":"https://secwatch.observer/filing/0001493152-25-025378.json","markdown":"https://secwatch.observer/filing/0001493152-25-025378.md","text":"https://secwatch.observer/filing/0001493152-25-025378.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2017950/000149315225025378/0001493152-25-025378-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2017950/000149315225025378/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:17:36.233745+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}